Correspondence to Dr David T Ewart, Division of Rheumatic and Autoimmune Diseases, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA; ewar0001{at}umn.edu and ...

Objectives: To compare the efficacy and tolerability of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day used to attain a target serum urate concentration (sUr) ⩽0.30 mmol/l (5 mg/dl).

Over the past decades, the concept of ‘remission’ has emerged as a moniker for the disease state one would ideally like to achieve when a ‘cure’—the ultimate goal of medical intervention—cannot ...

Background NeceSSity stands for “New Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients”. International consortium involving 25 partners (20 ...

1 The George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia 4 Institute of Bone and Joint Research, The Kolling Institute, Sydney Medical ...

Background: The Bath Ankylosing Spondylitis Metrology Index (BASMI) characterises the spinal mobility of patients with ankylosing spondylitis. Two versions have been published using categorical scores ...

Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid ...

4 National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing, China Objectives To evaluate the associations of regular glucosamine use with all-cause and ...

1 School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, UK 2 Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, UK Correspondence to ...